Frequency Nerve Block News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article
Share this article
CLEVELAND and ALISO VIEJO, Calif., Jan. 7, 2021 /PRNewswire/  Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the close of a Series BB financing totaling $38.5 million. 
The financing was co-led by new investors Amzak Health and Sectoral Asset Management, joined by InCube Ventures, existing investors U.S. Venture Partners, Osage University Partners, and Aperture Venture Partners, and other existing and new investors. Joyce Erony of Amzak Health and Marc-Andre Marcotte of Sectoral Asset Management have joined Neuros Board of Directors.  Andrew Farquharson of InCube Ventures is serving as a Board Observer.  ....

United States , Kevin Kilgore , Marc Andre Marcotte , Niloy Bhadra , Joyce Erony , Andrew Farquharson , Tom Wilder , Amy Smith , Amzak Health , Neuros Medical Inc , Company Altius , Osage University Partners , Case Western Reserve University , Neuros Medical , Sectoral Asset Management , Incube Ventures , Aperture Venture Partners , Neuro Board , Nerve Block , Amputation Pain , Investigational Device Exemption , Frequency Nerve Block , Chief Executive , Phantom Limb Pain , Residual Limb Pain , High Frequency Nerve ,